DNA methylation (DNAm) is heritable and plays a role in brain development and function through transcriptional regulation. Aberrant DNAm in human brain has been linked to psychiatric disorders, potentially as mediators of common genetic risk variants. In this study, we hypothesize that common risk variants for psychiatric disorders may act through affecting DNAm level in human brain. We first aimed to investigate the heritability pattern of DNAm levels in the human prefrontal cortex. Secondly, through imputation-driven methylome-wide association study (MWAS), we aimed to identify CpG sites whose methylation levels are genetically associated and that show methylation-trait associations in the prefrontal cortex of patients with schizophrenia or bipolar disorder. Our heritability analysis showed that, of ~370,000 CpG sites measured with the Illumina HumanMethylation450 microarray, 17% were heritable (p < 0.05), with a mean heritability of 0.22. Heritable CpG sites were enriched in intergenic regions, CpG shore, and regulatory regions in prefrontal cortex. Our MWAS approach identified known and potentially novel risk genes harboring CpG sites of methylation-trait associations for schizophrenia or bipolar disorder, which were not detectable using three alternative strategies (blood-based methylome reference, transcriptome-wide association study, and two gene-based association tests). Gene set enrichment analysis for genes with methylation-trait association evidence revealed pathways clearly related to neuronal functions, but also highlighted additional biological mechanisms that may underlie psychiatric disorders, such as microRNA-related regulation. In conclusion, our results showed the power of integrating brain methylation data with GWAS for psychiatric risk gene discovery, with potential applications in brain-related disorders or traits.
Introduction
DNA methylation (DNAm) is heritable and plays a critical role in brain development and function through transcriptional regulation (1, 2). Family and twin studies have investigated the heritability of DNAm for sites across the genome in easily accessible tissues (3-7), but, to our knowledge, there have been limited studies of methylation heritability in brain tissue. Indeed, only one study estimated the heritability of DNAm levels of individual CpG dinucleotides attributable to local single nucleotide polymorphisms (SNPs) in postmortem brain from unrelated individuals, but the estimation was limited to ~21,000 CpG sites primarily within promoters (8). The heritability pattern is not known for DNAm sites within gene body or intergenic regions, which represent a large portion of DNAm variation and are potentially important in epigenetic regulation of gene expression (9-12).
Aberrant DNAm has been linked to psychiatric disorders in candidate gene analysis and epigenome-wide association studies (EWAS) of schizophrenia (SCZ) (13, 14) , bipolar disorder (BD) (15), and major depressive disorder (16, 17) . However, the majority of these studies have been of easily accessible HumanMethylation450 (450k) microarray, which measures CpG methylation across >485,000 probes.
The current study used DNAm data from 238 unrelated subjects of European ancestry (100 SCZ patients and 138 controls), defined by principal component analysis (PCA) of GWAS data collected from the same samples. DNAm data were processed and normalized using the Minfi Bioconductor package in R (32). GWAS data were imputed into 1000 Genomes Phase 3 variants using SHAPEIT2 (33) and IMPUTE2 (34). After filtering out SNPs with MAF < 5%, HWE p-value < 0.05, or missing rate > 10%, there were 4,402,285 SNPs on autosomes retained for further analyses. Information on tissue processing, experimental and bioinformatics procedures related to the methylation data, and genotype data processing was described in prior reports (1, 13).
We downloaded GWAS summary statistics from the Psychiatric Genomic Consortium (PGC) website (https://www.med.unc.edu/pgc/) for SCZ and BD. We then applied an imputation-driven methylomewide association study (MWAS) to the PGC2 GWAS meta-analysis summary statistics. We retained autosomal SNPs with MAF > 0.05 and imputed quality score > 0.8. Coordinates of SNPs were aligned to hg19 for all datasets.
Predicting the cis-genetic component of DNAm
We evaluated whether the DNAm levels of heritable CpGs could be imputed from the genotype data for SNPs within 1 Mb of the CpG. We used fivefold cross-validation to compare predictive performance of three modeling schemes: top SNP, polygenic score and elastic net. Of the 32,949 CpGs for which all three models were successfully built, we found that the elastic net approach achieved the best performance with an average R 2 =0.24, followed by the polygenic score (R 2 =0.16), and the top SNP methods (R 2 =0.095) (Figure 2a ). When models were compared on the same CpG sites, 80% of the CpG sites achieved the best prediction by elastic net, whereas 18% and 2% of CpG sites were best predicted by the polygenic score and the top SNP methods, respectively ( Figure 2b ). Using heritability estimates as a benchmark for prediction R 2 , we compared the prediction R 2 with the heritability estimate for each CpG ( Figure 2c ). We found that 89% of the CpGs achieved an R 2 equal to or larger than the lower bound of heritability estimate by elastic net, whereas 68% (polygenic score) and 39% (top SNP) of CpGs achieved such performance with the other methods . Overall, the elastic net approach showed the best performance for predicting DNAm levels based on different evaluation strategies. The effect sizes derived from elastic net were then used to impute differential methylation statistics from GWAS summary statistics.
extended major histocompatibility complex region (chr6:25652464-33771788); 31 CpG sites were located more than 1 Mb away from any GWS SNPs from PGC2 SCZ GWAS, suggesting potential novel signals not detected by GWAS. Table 1 shows details and methylation-trait association statistics for the 20 CpG sites mapped to 24 genes. Of note, the gene MORC2-AS1 was far from GWS in PGC2 SCZ GWAS (smallest p = 1.5×10 -5 , 1 Mb window), but contained a CpG site at a gene body with strong evidence for methylation-trait association (cg13896476, p = 3.4×10 -10 ). Another CpG site, at promoter of MORC2-AS1, also showed significant evidence for methylation-trait association (cg08837037, p = 1.5×10 -8 , Supplementary Table 1 ). Figure 4 shows the regional association plot of methylation-trait associations around MORC2-AS1, along with SNP association signals from GWAS and how their weights contribute to the top significant CpG.
We identified 28 GWS CpGs with methylation-trait association evidence for BD (Figure 3b,   Supplementary Table 2 ). Of these, 14 overlapped original GWAS risk loci and 14 were at least 1 Mb away from any GWS SNPs. Table 2 shows details and methylation-trait association statistics for the 10
CpG sites mapped to 11 unique genes. Notably, CNIH2, which encodes a subunit of the ionotropic glutamate receptor in the human brain, showed strong evidence for methylation-trait association at a CpG site in the promoter region (cg19026260, p=8.9×10 -9 ), whereas the strongest GWAS signals within 1 Mb of CNIH2 was only at p = 2.1×10 -7 . Figure 5 shows the regional association plot of methylation-trait associations around CNIH2, along with SNP association signals from GWAS and how their weights contribute to the top significant CpG.
Comparison with alternative analytical strategies
We evaluated three alternative strategies in their ability to detect the potential novel risk genes discovered above, which were at least 1 Mb away from any GWS SNPs (Supplementary Table 3 ). Among the 24 potential novel risk genes from PGC2 SCZ, only five genes were detected: TMX2 (GATES, p = 6.9×10 -7 ;
VEGAS-sum, p = 1.0×10 -6 ), C11orf31 (VEGAS-sum, p = 1.0×10 -6 ), CORO7 (TWAS, p=2.3×10 -7 ), TMTC1 (TWAS, p = 1.8×10 -8 ), and BCL2L12 (VEGAS-sum, p = 2.0×10 -6 ). For the ten potential novel risk genes from PGC2 BD, only PACS1 was identified (VEGAS-sum, p=1.0×10 -6 ).
Gene set enrichment analysis
We conducted gene set enrichment analyses to examine whether genes with methylation-trait associations clustered into biological functional groups. Full gene set analysis results are shown in Supplementary genes encoding voltage-gated calcium channels, genes related to membrane depolarization during action potential, genes associated with SCZ (p <10 -4 ), autism de novo genes (orange); 4) microRNA targets, SCZ de novo genes (blue); 5) microRNA targets, chromatin regulator CHD8 targets (red); 6) genes involved in antigen processing and presentation, genes associated with BP (p <10 -4 ) (brown); 7) genes involved in cell adhesion (black); 8) genes involved in axoneme assembly (dark blue).
Supplementary Figure 3 shows summary results for 51 gene sets with enriched methylation-trait association evidence for BD (q-values ≤ 0.05). Gene sets were grouped into five major clusters. The highlighted gene sets in each cluster include: 1) microRNA targets, SCZ de novo genes, and genes involved in cell adhesion (blue); 2) RBFOX1, RBFOX2, RBFOX3 regulatory networks, FMRP targets, synaptome, mutation intolerant genes (red); 3) genes involved in synaptic plasticity and transmission (green); 4) ion channel genes, missense constrained genes, calcium signaling pathway (purple); 5) genes involved in integrin signaling, genes associated with BP and depression (p <10 -4 ) (orange).
Discussion
In the current study, we have shown that DNAm levels are heritable for ~17% of the CpG sites examined in human prefrontal cortex. Heritable DNAm sites tended to be more variable and enriched in intergenic and regulatory regions in brain. Through imputation of methylation-trait association from GWAS summary statistics, we identified known and potentially novel risk genes with methylation-trait association evidence that were not detectable using three alternative strategies. Gene set enrichment analysis for genes with methylation-trait association evidence revealed pathways related to neuronal functions, as well as other biological mechanisms potentially underlying psychiatric disorders, consistent with prior analyses based on GWAS (46) and gene expression data (47-49) .
Heritability estimates of DNAm levels may vary across tissues and study designs. Twin studies reported an average heritability of 12-18% in whole blood (7, 50), 5% in placenta (7), and 19% in adipose tissue (28). A family study showed an average heritability of 13% in CD4 + cells (3). One study reported an average SNP-heritability of 29% across heritable CpG sites in colorectum (51). There has been to date only one study that estimated the SNP-heritability of DNAm in brain, but that was limited to ~27,000
CpGs located primarily in promoters (8). We found modest correlation of heritability estimates (r = 0.48) for a common subset of CpGs between our study and the frontal cortex results of Quon et al (8) . The variation of heritability estimates may be attributable to differences in brain samples and analytical approach. For example, we used a more narrowly defined single prefrontal cortical region---dorsolateral prefrontal cortex---from samples with a wide range of ages, whereas Quon et al used the whole frontal cortex largely from adults; we used SNPs within 1 Mb window of CpGs, but Quon et al used a window size of 50 kb. Importantly, our study differs from the previous one by virtue of a more than tenfold increase of CpG sites (~380,000) across a much broader portion of the genome, including intergenic and gene body regions. In addition, our study has a larger sample size than the previous one (238 versus 150) and thus higher power to detect heritable CpG sites. We found a higher mean heritability for CpG sites in intergenic regions than for those at promoter regions. We also observed that heritable CpG sites tended to be located in intergenic regulatory genomic regions, suggesting a potentially important role in regulation of gene expression.
We evaluated three modeling schemes for their ability to predict the cis-genetic component of DNAm levels for CpG sites with a nominal significance level for heritability estimates. We found the highest performance for elastic net and the lowest performance for the top SNP method, suggesting that DNAm levels tend to be influenced by multiple SNPs. This observation is consistent with the result from a previous study in which elastic net achieved the best performance for predicting the cis-genetic component of gene expression using SNPs within 1 Mb of a gene (52). Future work might employ other approaches to improve the prediction accuracy for DNAm levels. For example, recent work has included imputation of gene expression using the best linear predictor and the Bayesian linear mixed model (38), which can also be evaluated for DNAm prediction in the future.
Compared to a single marker association, the proposed MWAS features similar advantages as the TWAS method that aims to impute expression-trait association from GWAS summary statistics. In summary, we have shown the heritability pattern of DNAm in human prefrontal cortex. We further demonstrated the power of integrating the brain methylome with GWAS for psychiatric risk gene discovery, an approach which has potential applications in other brain-related disorders or traits.
